title: Protective effect of (4-methoxybenzylidene)-(3-methoxynophenyl)amine against neuronal cell death induced by oxygen and glucose deprivation in rat organotypic hippocampal slice culture.
abstract: Resveratrol (trans-3,4',5-trihydroxystilbene) is a natural phytoalexin found in grape skin, and has been suggested to be an antioxidant agent, an anticancer agent and a cardioprotective agent. In particular, recent experimental evidence has demonstrated that resveratrol exhibits neuroprotective effects in various assay systems. During the study on the resveratrol derivatives, we found that (4-methoxybenzylidene)-(3-methoxyphenyl)amine (MBMPA), which has blocked free phenolic groups, strongly protects neuronal cells against ischemic damage on a higher activity than resveratrol. The MBMPA potently reduced the level of neuronal cell death in an oxygen and glucose deprivation-exposed rat organotypic hippocampal slice culture. In addition, ATP depletion following the onset of oxygen and glucose deprivation in an adult hippocampal slice was blocked by the MBMPA treatment. These results suggest that MBMPA has a neuroprotective effect on an in vitro ischemia model, and may be useful for treating stroke.
authors.affiliation: Korea Food Research Institute, Songnam. sychoi@kfri.re.kr
authors.forename: Sang Yoon
authors.initials: SY
authors.lastname: Choi
authors.forename: Sanghee
authors.initials: S
authors.lastname: Kim
authors.forename: Dongwook
authors.initials: D
authors.lastname: Son
authors.forename: Pyeongjae
authors.initials: P
authors.lastname: Lee
authors.forename: Jongseok
authors.initials: J
authors.lastname: Lee
authors.forename: Sanghyun
authors.initials: S
authors.lastname: Lee
authors.forename: Dong Soo
authors.initials: DS
authors.lastname: Kim
authors.forename: Yongkon
authors.initials: Y
authors.lastname: Park
authors.forename: Sun Yeou
authors.initials: SY
authors.lastname: Kim
mesh_terms: D000255:Adenosine Triphosphate / Q000378:metabolism; D000814:Aniline Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D000818:Animals; D001593:Benzyl Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D002545:Brain Ischemia / Q000188:drug therapy; D015687:Cell Hypoxia; D002470:Cell Survival / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D005947:Glucose / Q000172:deficiency*; D006624:Hippocampus / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D009474:Neurons / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D018696:Neuroprotective Agents / Q000494:pharmacology* / Q000627:therapeutic use; D009924:Organ Culture Techniques; D051381:Rats; D017207:Rats, Sprague-Dawley; D000077185:Resveratrol; D013267:Stilbenes / Q000494:pharmacology
chemical_list: C517754:(4-methoxybenzylidene)-(3-methoxynophenyl)amine; D000814:Aniline Compounds; D001593:Benzyl Compounds; D018696:Neuroprotective Agents; D013267:Stilbenes; D000255:Adenosine Triphosphate; D005947:Glucose; D000077185:Resveratrol